CARDERO RESOURCE
Oculis Holding AG, a clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases in Switzerland, Iceland, and internationally. The company's lead product candidate is OCS-01, a topical dexamethasone optireach formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b cli… Read more
Market Cap & Net Worth: CARDERO RESOURCE (CR5)
CARDERO RESOURCE (F:CR5) has a market capitalization of $1.36 Billion (€1.33 Billion) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #7563 globally and #808 in its home market, demonstrating a -1.71% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CARDERO RESOURCE's stock price €23.00 by its total outstanding shares 57806909 (57.81 Million).
CARDERO RESOURCE Market Cap History: 2021 to 2026
CARDERO RESOURCE's market capitalization history from 2021 to 2026. Data shows growth from $492.50 Million to $1.36 Billion (27.29% CAGR).
CARDERO RESOURCE Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CARDERO RESOURCE's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of CR5 by Market Capitalization
Companies near CARDERO RESOURCE in the global market cap rankings as of March 18, 2026.
Key companies related to CARDERO RESOURCE by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
CARDERO RESOURCE Historical Marketcap From 2021 to 2026
Between 2021 and today, CARDERO RESOURCE's market cap moved from $492.50 Million to $ 1.36 Billion, with a yearly change of 27.29%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €1.36 Billion | +15.00% |
| 2025 | €1.19 Billion | +81.82% |
| 2024 | €652.71 Million | +10.55% |
| 2023 | €590.41 Million | +8.74% |
| 2022 | €542.94 Million | +10.24% |
| 2021 | €492.50 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of CARDERO RESOURCE was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.36 Billion USD |
| MoneyControl | $1.36 Billion USD |
| MarketWatch | $1.36 Billion USD |
| marketcap.company | $1.36 Billion USD |
| Reuters | $1.36 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.